Trials / Completed
CompletedNCT01332539
An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective. As control group, 120 patients with controlled partial epilepsy will be enrolled. The objective of the study is to describe the burden of illness in this epileptic population both in terms of costs and of quality of life. Costs and quality of life will be also compared between the two populations.
Detailed description
observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | non-interventional study |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2011-04-11
- Last updated
- 2013-05-27
Source: ClinicalTrials.gov record NCT01332539. Inclusion in this directory is not an endorsement.